BlackRock Fund Advisors - KALOBIOS PHARMACEUTICALS INC ownership

KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 18 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of KALOBIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$64,000
-40.2%
131,165
+111.4%
0.00%
Q4 2014$107,000
+137.8%
62,043
+114.6%
0.00%
Q3 2014$45,000
-36.6%
28,916
-6.8%
0.00%
Q2 2014$71,000
-91.9%
31,024
-90.4%
0.00%
Q1 2014$880,000
-36.9%
324,571
+2.9%
0.00%
Q4 2013$1,395,000
+21.5%
315,574
+24.3%
0.00%
Q3 2013$1,148,000
-9.6%
253,977
+13.2%
0.00%
Q2 2013$1,270,000224,3580.00%
Other shareholders
KALOBIOS PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Opus Point Partners Management, LLC 746,467$358,0000.28%
HARBOURVEST PARTNERS LLC 57,604$28,0000.01%
PRIMECAP MANAGEMENT CO/CA/ 4,327,600$2,077,0000.00%
Renaissance Technologies 564,673$271,0000.00%
VALLEY WEALTH MANAGERS, INC. 15,861$8,0000.00%
CITIGROUP INC 2,745$1,0000.00%
GOLDMAN SACHS GROUP INC 14,456$7,0000.00%
BLAIR WILLIAM & CO/IL 53,635$25,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 86,700$42,0000.00%
Tower Research Capital LLC (TRC) 3,055$1,0000.00%
View complete list of KALOBIOS PHARMACEUTICALS INC shareholders